Total Credits: 3 including 3 Category I CEs
This three-hour introductory immersive workshop provides practitioners with essential knowledge and best practices for preparing clients for psychedelic journeys. This includes ensuring a safe and supportive environment. Key topics covered will include building a strong therapeutic relationship, the ethical use of touch, the role of music in enhancing the experience, and strategies for managing subjective experiences and side effects. Participants will also explore the importance of cultural humility in this emerging field, ensuring that care is inclusive, intersectional, and respectful of diverse backgrounds and identities.
Candace Oglesby is a licensed professional counselor (LCPC) in the state of Maryland. Candace began her career as a psychedelic-assisted therapy therapist in 2020, when she sat on her first research study that investigated the effects of psilocybin in cancer and TRD patients. Since then, she has gained training in Ketamine, MDMA, and 5-MeO-DMT assisted therapies.
In addition, Candace is the founder and owner of Jurnee Mental Health Consulting, LLC, which provides support to individuals and businesses looking to deepen their understanding of mental health and provides support and resources to global majority communities. Candace also serves as a DEI mental health consultant, trainer, speaker, and mentor within the psychedelic community. When Candace is not acting as psychotherapist, consultant, trainer, and mentor, she is spending time with her husband, family, and friends. Candace believes that cutting-edge therapies and techniques should be made available to everyone despite race, sexual orientation, gender, or socioeconomic status.
Sunstone Therapies: Clinical Research Findings, Therapist Training Challenges, and Future Directions in Psychedelic-Assisted Therapy
Fri, Nov 22, 2024 - 12:00pm to 01:30pm EST |
Honoring Indigenous Wisdom: History of Indigenous practices with psychedelic medicines and practitioner responsibilities in (Psychedelic Assisted Therapy) PAT
Fri, Jan 24, 2025 - 12:00pm to 01:30pm EST |
Liberation-Informed Psychedelic Care: Healing Beyond our Trauma
Fri, Feb 28, 2025 - 12:00pm to 01:30pm EST |
Foundations of Psychedelic Harm Reduction and Integration Therapy
Fri, Mar 28, 2025 - 12:00pm to 03:15pm EDT |
Expanding Access to Psychedelic-Assisted Therapy – Reimbursement, Provider Networks, and Employer-Sponsored Benefits
Fri, Apr 25, 2025 - 12:00pm to 01:30pm EDT |
Upon the completion of this workshop, participants will be able to:
Describe an ethical framework for supporting clients through PAP, emphasizing boundaries, consent, and professional integrity.
Summarize clinical tools for addressing and navigating the emotional, psychological, and physical effects that may arise during a psychedelic experience.
Identify components of cultural humility critical to preparing to facilitate PAP, ensuring inclusive care that respects clients' diverse backgrounds and identities.
BIBLIOGRAPHY & REFERENCES
Barrett, F. S., Bradstreet, M. P., Leoutsakos, J. S., Johnson, M. W., & Griffiths, R. R. (2016). The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms. Journal of Psychopharmacology, 30(12), 1279–1295. https://doi.org/10.1177/0269881116678781
Gashi, L., Sandberg, S., & Pedersen, W. (2021). Making “bad trips” good: How users of psychedelics narratively transform challenging trips into valuable experiences. International Journal of Drug Policy, 87, 102997. https://doi.org/10.1016/j.drugpo.2020.102997
Gasser, P., Kirchner, K., & Passie, T. (2015). LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects. Journal of Psychopharmacology, 29(1), 57–68. https://doi.org/10.1177/0269881114555249
Hovmand OR, Poulsen ED, Arnfred S. Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics. J Psychopharmacol. 2024 Jan;38(1):19-32. doi: 10.1177/02698811231200019. Epub 2023 Nov 16. PMID: 37969069; PMCID: PMC10851631.
Johnson, M. W., Griffiths, R. R., & Griffiths, R. R. (2017). Psychedelics and psychedelic-assisted psychotherapy: Implications for clinical psychiatry. Biological Psychiatry, 76(5), 340–348. https://doi.org/10.1016/j.biopsych.2017.05.012
Kaelen, M., Giribaldi, B., & Raine, J. (2018). Music as a co-therapist in psychedelic-assisted psychotherapy. Frontiers in Psychology, 9, 434. https://doi.org/10.3389/fpsyg.2018.00434
Neitzke-Spruill, L. (2019). Race as a component of set and setting: How experiences of race can influence psychedelic experiences. Journal of Psychedelic Studies, 4(1), 51–60. https://doi.org/10.1556/2054.2019.022
Nielson, E. M., & Guss, J. (2018). Ethical considerations in psychedelic therapy. Journal of Humanistic Psychology, 58(5), 567–584. https://doi.org/10.1177/0022167817711300
Phelps, J. (2017). Developing guidelines and competencies for the training of psychedelic therapists. Journal of Humanistic Psychology, 57(5), 450–487.
Sunstonether. (2024, May 22). Psychedelics: Subjectivity in the therapeutic response. Sunstone Therapies. https://www.sunstonetherapies.com/news/psychedelics-subjectivity-in-the-therapeutic-response/
Tupper, K. W., Wood, E., Yensen, R., & Johnson, M. W. (2015). Psychedelic medicine: A re-emerging therapeutic paradigm. Canadian Medical Association Journal, 187(14), 1054–1059. https://doi.org/10.1503/cmaj.141124
Williams, M. T., Reed, S., & George, J. R. (2020). Psychedelic medicine and cultural trauma: Toward a culturally-informed psychedelic-assisted therapy. Journal of Psychedelic Studies, 4(1), 40–53. https://doi.org/10.1556/2054.2020.00122
Yaden, D. B., & Griffiths, R. R. (2020). The subjective effects of psychedelics are necessary for their enduring therapeutic effects. ACS Pharmacology & Translational Science, 4(2), 568–572. https://doi.org/10.1021/acsptsci.0c00194
Category I Maryland BSWE Requirement
The Office of Continuing Professional Education at the University Of Maryland School Of Social Work is authorized by the Board of Social Work Examiners in Maryland to sponsor social work continuing education programs. This workshop qualifies for 3 Category I Continuing Education Units. The Office of Continuing Professional Education is also authorized by the Maryland Board of Psychologists and the Maryland Board of Professional Counselors to sponsor Category A continuing professional education.
Please refer to the tab "Live Interactive Webinar Policies & FAQs" for UMSSW Office of CPE policies regarding all live interactive webinar related matters.
Social Workers, LCPCs, and Psychologists
We welcome anyone interested in the topic!
The base price is $60, which includes CE credit.
Cancellations: **ALL cancellations will be subjected to a $35.00 administration fee.** Cancellations must be received 24 hours in advance prior to the workshop to receive a refund or an account credit.
LIVE INTERACTIVE WEBINAR PLATFORMS
The Office of Continuing Professional Education hosts Live Interactive Webinars through Zoom. This platform offers a high quality and user-friendly webinar platform for our registrants.
System Requirements:
Our system is not compatible with the Safari web browser.
**Please have your device charging at all times to ensure that your device does not lose power during the webinar.
Course Interaction Requirements:
To participate in Live Interactive Webinars, you MUST have a device that allows you to view the presentation on screen and hear the instructor at all times. We do not allow participants to call-in from their phones or mobile devices and solely listen to the presentation. Participation in Live Interactive Webinars is mandatory.
Click The Link to View The Webinar Policies & FAQs
https://umbsswcpe.ce21.com/Page/live-interactive-webinar-procedures-policies-4129
If you are requesting ADA accommodations, please contact our office via email at least two weeks prior to the workshop date. Requests after that date may not be fulfilled.
Our email address is cpe@ssw.umaryland.edu.